Filter
1730
Text search:
molecular
Featured
Recommendations
204
New Publications
314
Language
Document type
No document type
718
Guidelines
386
Studies & Reports
333
Manuals
111
Strategic & Response Plan
77
Fact sheets
51
Training Material
24
Situation Updates
11
Resource Platforms
10
Infographics
7
Brochures
1
Videos
1
Countries / Regions
India
95
Global
70
Latin America and the Carribbean
66
Brazil
53
Western and Central Europe
50
Eastern Europe
36
Africa
35
Kenya
29
Colombia
28
South Africa
26
Tanzania
24
Ethiopia
21
West and Central Africa
17
Venezuela
17
Russia
17
Peru
15
Uganda
14
Mozambique
14
East and Southern Africa
14
Paraguay
14
Germany
13
Argentina
13
South–East Asia Region
13
Rwanda
12
El Salvador
12
Nigeria
11
Zambia
11
Malawi
11
Namibia
11
Asia
11
Sierra Leone
10
Philippines
10
Nepal
10
Angola
10
Congo, Democratic Republic of
9
Ukraine
9
Bolivia
9
Liberia
8
Senegal
8
Ghana
8
Zimbabwe
7
Indonesia
7
Bangladesh
7
Ecuador
7
Chile
7
Syria
6
Myanmar / Burma
6
Middle East and North Africa
6
Vietnam
6
Spain
6
Pakistan
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Guinea-Bissau
4
USA
4
Cameroon
4
Cambodia
4
France
4
Guinea
3
Burkina Faso
3
Haiti
3
Lebanon
3
Thailand
3
China
3
Benin
3
Eswatini/ Swaziland
3
Botswana
3
North America
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Niger
2
Somalia
2
South Sudan
2
Jordan
2
Turkey
2
Chad
2
Mauritania
2
Dominican Republic
2
Honduras
2
Libya
2
Guatemala
2
Mexico
2
Tajikistan
2
Georgia
2
Uruguay
2
United Kingdom
2
Portugal
2
Morocco
1
Saudi Arabia
1
Iraq
1
Afghanistan
1
Egypt
1
Gambia
1
Malaysia
1
Sudan
1
North Macedonia
1
Cuba
1
Madagascar
1
Lesotho
1
Nicaragua
1
Sri Lanka
1
Yemen
1
Palestine
1
Italy
1
Laos
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Qatar
1
Estonia
1
Romania
1
Iran
1
Kazakhstan
1
Turkmenistan
1
Japan
1
Tunisia
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
569
Clinical Guidelines
207
Public Health
74
Pharmacy & Technologies
69
Key Resources
33
Women & Child Health
19
Capacity Building
11
Toolboxes
TB
357
COVID-19
248
NTDs
152
AMR
104
HIV
94
Mental Health
78
Malaria
53
Ebola & Marburg
46
Rapid Response
45
Planetary Health
39
Zika
31
Pharmacy
30
NCDs
26
2.0 Rapid Response
21
Refugee
16
Polio
13
Specific Hazards
11
Cholera
10
Caregiver
9
Disability
8
Global Health Education
7
Health Financing Toolbox
6
Conflict
4
Natural Hazards
4
In conclusion, the current evidence does not support the use of mpox antigen RDTs in the field. More data are expected from independent evaluations conducted by Africa CDC, FIND or other organizations
This document aims to describe a minimum set of surveillance activities recommended at the national level to detect and monitor the relative prevalence of SARS-CoV-2 variants and outline a set of activities for the characterization and assessment of risk posed by these variants. A set of indicators
...
The update of the ESTC was conducted as a joint endeavour with ERS, consulting experts from international societies and organisations, national TB programmes, civil society and affected communities. The second edition of the ESTC includes 21 standards in the areas of diagnosis, treatment, HIV and co
...
China is one of the major countries for the production and use of antibacterial agents. Antibacterial agents are widely used in healthcare and animal husbandry. It plays a significant role in treating infections and saving patient lives, preventing and treating animal diseases, improving farming ef
...
WHO-2019-nCoV-genomic_sequencing
PLoS ONE 12(7): e0180996. https://doi.org/10.1371/journal.pone.0180996
This Review summarizes many of the persistent biological alterations associated with childhood maltreatment including changes in neuroendocrine and neurotransmitter systems and pro-inflammatory cytokines in addition to specific alterations in brain areas associated with mood regulation. Finally, I d
...
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19
recommended
ASLM in collaboration with the Africa Centres for Disease Control and Prevention, and in partnership with the Clinton Health Access Initiative, Amref and Last Mile Health present the Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19. This framework aims to pr
...
Death investigation sheet concerning tuberculosis: Other Health Units and with family members
Three classess of tests are now recommended in the latest consolidated guideles on tests for tuberculosis infection. It includes for the first-time a new class of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), and the two existing classes of tests: the tuberculin skin test (TST) and t
...
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh
...
The Africa Centres for Disease Control and Prevention (Africa CDC) Biosafety and Biosecurity Initiative was launched by the Africa CDC in April 2019 with the aim of strengthening the African Union (AU) Member States’ biosafety and biosecurity systems and enabling them to comply with national and i
...
Estas Normas pretendem ser um instrumento de apoio ao profissional
de saúde afecto às Unidades Sanitárias, à todos os níveis de atenção de
saúde para o diagnóstico, tratamento e seguimento da HTA, bem como
prevenção das complicações
A printable copy of the article published in Morbidity and Mortality Weekly Report (MMWR) can be found on the CDC Homepage. Follow the Download Link for redirection to CDC.
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.